Zobrazeno 1 - 10
of 327
pro vyhledávání: '"ACE, angiotensin converting enzyme"'
Autor:
DuoYao Cao, Suguru Saito
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/6e376fcac99c436aa19d5cd4974d046b
Autor:
Wenyue Zheng, Erkang Tian, Zhen Liu, Changhan Zhou, Pei Yang, Keyue Tian, Wen Liao, Juan Li, Changyu Ren
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Angiotensin-converting enzyme (ACE), a zinc metalloprotein, is a central component of the renin–angiotensin system (RAS). It degrades bradykinin and other vasoactive peptides. Angiotensin-converting-enzyme inhibitors (ACE inhibitors, ACEIs) decreas
Externí odkaz:
https://doaj.org/article/18976cb8971e4aebb62a57bc848a971d
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The free-living, non-parasitic nematode Caenorhabditis elegans is a premier model organism for the study of aging and longevity due to its short lifespan, powerful genetic tools, and conservation of fundamental mechanisms with mammals. Approximately
Externí odkaz:
https://doaj.org/article/082a27e2cb974c86889a70300fc25c8c
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Coronaviruses (CoVs) are enveloped RNA viruses and have been shown to cause mild to severe respiratory infections in humans, with some severe cases inducing neurological manifestations. The lethality and Neurological effects of the Severe Acute Respi
Externí odkaz:
https://doaj.org/article/0527319ddcc94fe4960314b364255e3c
Publikováno v:
Frontiers in Pediatrics, Vol 8 (2020)
Externí odkaz:
https://doaj.org/article/ddd31bab68b444308aaf790749712e41
Autor:
Wiam Hmimech, Hind Hassani Idrissi, Brehima Diakite, Farah Korchi, Dalila Baghdadi, Hind Tahri Joutey Hassani Idrissi, Meriem Haboub, Rachida Habbal, Sellama Nadifi
Publikováno v:
BMC Research Notes, Vol 10, Iss 1, Pp 1-6 (2017)
Abstract Objective Our case–control study aimed to access the potential association of insertion/deletion (I/D) ACE (angiotensin converting enzyme) gene polymorphism with myocardial infarction (MI) risk of occurrence among a sample of Moroccan pati
Externí odkaz:
https://doaj.org/article/a90a35209af243f4afc623c2a55461f1
Publikováno v:
Journal of Clinical and Experimental Hepatology
Coronavirus disease 2019 (COVID-19) is associated with a significant morbidity and mortality in patients with cirrhosis. There is a significantly higher morbidity and mortality due to COVID-19 in patients with decompensated cirrhosis as compared to c
Autor:
Prashantha Hebbar, Ibrahim Taher, Thangavel Alphonse Thanaraj, Abdulrahman Almaeen, Hossein Arefanian, Jehad Abubaker, Arshad Channanath, Mohamed Abu-Farha, Amany A. Ghazy, Sumi Elsa John, Fahd Al-Mulla
Publikováno v:
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6645-6652 (2021)
Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6645-6652 (2021)
The outbreak of coronavirus disease 2019 (COVID-19) was caused by the newly emerged corona virus (2019-nCoV alias SARS-CoV-2) that resembles the severe acute respiratory syndrome virus (SARS-CoV). SARS-CoV-2, which was first identified in Wuhan (Chin
Autor:
Mohd Asyiq Al-Fard bin Mohd Raffali, Hamat Hamdi Che Hassan, Syawal Faizal Muhammad, Patrick Tiau Wei Jyung, Awatif Zohdi, Diyana Farouk
Publikováno v:
JACC Case Reports
A 33-year-old woman with newly diagnosed disseminated tuberculosis presented with acute heart failure and incidental findings of intracardiac thrombus, demonstrating possible tuberculous myocarditis. (Level of Difficulty: Intermediate.)
Central
Central
Autor:
Muthiah Vaduganathan, John Fanikos, Hessam Kakavand, Manuel Monreal, Deepak L. Bhatt, Sahil A. Parikh, Isaac Dreyfus, Gregg W. Stone, Peter Libby, Behnood Bikdeli, Benjamin W. Van Tassell, Harlan M. Krumholz, Samuel Z. Goldhaber, Hamid Ariannejad, David Jiménez, Aakriti Gupta, Gregory Piazza, Mahesh V. Madhavan, Gregory Y.H. Lip, Dave L. Dixon, Maryam Aghakouchakzadeh, Parham Sadeghipour, Azita Hajhossein Talasaz
Publikováno v:
Journal of the American College of Cardiology
Coronavirus disease-2019 (COVID-19) is associated with systemic inflammation, endothelial activation, and multiorgan manifestations. Lipid-modulating agents may be useful in treating patients with COVID-19. These agents may inhibit viral entry by lip